Abstract | PURPOSE OF REVIEW: RECENT FINDINGS: SUMMARY:
Gallium nitrate has demonstrated activity against lymphoma and bladder cancer, which is likely the result of selective targeting of these malignancies. An important property of gallium nitrate is that it is not myelosuppressive and it lacks cross-resistance to other drugs. Further investigations are needed to understand better its molecular targets and to determine its clinical efficacy in combination with other drugs.
|
Authors | Christopher R Chitambar |
Journal | Current opinion in oncology
(Curr Opin Oncol)
Vol. 16
Issue 6
Pg. 547-52
(Nov 2004)
ISSN: 1040-8746 [Print] United States |
PMID | 15627016
(Publication Type: Journal Article, Review)
|
Chemical References |
- Antineoplastic Agents
- Gallium
- gallium nitrate
|
Topics |
- Antineoplastic Agents
(therapeutic use)
- Clinical Trials as Topic
- Gallium
(therapeutic use)
- Humans
- Lymphoma
(drug therapy)
- Urinary Bladder Neoplasms
(drug therapy)
|